New Insights into Parkinson’s Disease: From Molecular Basis to Therapy
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 425
Special Issue Editor
Interests: genetics; neurodegeneration; Parkinson’s disease; Alzheimer’s disease; biomarkers; pharmacogenetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Parkinson’s disease (PD) is the second most common neurodegenerative disease affecting 1–2% of the population over the age of 65 years. About 90–95% of PD patients have sporadic disease attributed to interactions between environmental and genetic factors, whereas approximately 5–10% of PD cases are familial, following an autosomal dominant or autosomal recessive mode of inheritance. Advances in the field of genetics have aided the identification of specific genes and the recognition of molecular pathways relevant to PD pathogenesis.
In this Special Issue entitled “New Insights into Parkinson’s Disease: From Molecular Basis to Therapy”, submissions are invited (research articles, reviews, meta-analyses, case reports, etc.) that enhance our knowledge of the genetic background of PD, aiming to better delineate genetic and epigenetic contributions to disease progression, increase our understanding on the exact pathophysiologic mechanisms implicated in PD, utilize genetic information to facilitate the diagnosis and prediction of this disease, as well as enable more tailored and effective therapeutic approaches for patients experiencing this neurodegenerative disease.
Dr. Kallirhoe Kalinderi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Parkinson’s disease
- neurodegeneration
- genes
- GWAs
- polygenic risk score
- therapy
- precision medicine
- pathways
- pharmacogenetics
- surgicogenomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
